WallStreetZenWallStreetZen

NASDAQ: GANX
Gain Therapeutics Inc Earnings & Revenue

GANX past revenue growth

How has GANX's revenue growth performed historically?
Company
-60.62%
Industry
165.61%
Market
17.84%
GANX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GANX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GANX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GANX earnings and revenue history

Current Revenue
$55.2k
Current Earnings
-$22.3M
Current Profit Margin
-40,354.3%

GANX Return on Equity

Current Company
-193%
Current Industry
-63.6%
Current Market
188%
GANX's Return on Equity (-193%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GANX announces earnings.

GANX Return on Assets

Current Company
-123.2%
Current Industry
3%
GANX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GANX Return on Capital Employed

Current Company
-162.44%
Current Industry
19.6%
GANX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GANX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GANX$55.18k-$22.10M-$22.27M+21.77%N/A
CLGN$10.72M-$5.42M-$6.73M+64.31%N/A
IMMX$0.00-$14.11M-$14.14MN/AN/A
TSBX$19.31M-$52.69M-$55.24M-56.34%N/A
NXTC$0.00-$58.47M-$62.72M-100.00%N/A

GANX earnings dates

Next earnings date
May 10, 2024

Gain Therapeutics Earnings & Revenue FAQ

What were GANX's earnings last quarter?

On Invalid Date, Gain Therapeutics (NASDAQ: GANX) reported Q4 2023 earnings per share (EPS) of -$0.29, up 25.64% year over year. Total Gain Therapeutics earnings for the quarter were -$4.72 million. In the same quarter last year, Gain Therapeutics's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Gain Therapeutics stock.

What was GANX's earnings growth in the past year?

As of Q1 2024, Gain Therapeutics's earnings has grown year over year. Gain Therapeutics's earnings in the past year totalled -$22.27 million.

What is GANX's earnings date?

Gain Therapeutics's earnings date is Invalid Date. Add GANX to your watchlist to be reminded of GANX's next earnings announcement.

What was GANX's revenue last quarter?

On Invalid Date, Gain Therapeutics (NASDAQ: GANX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Gain Therapeutics's revenue was $0.00.

What was GANX's revenue growth in the past year?

As of Q1 2024, Gain Therapeutics's revenue has grown -60.62% year over year. This is 226.23 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Gain Therapeutics's revenue in the past year totalled $55.18 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.